Literature DB >> 24497894

A Conceptual Model of Psychoneurological Symptom Cluster Variation in Women with Breast Cancer: Bringing Nursing Research to Personalized Medicine.

Angela R Starkweather1, Debra E Lyon1, R K Elswick1, Alison J Montpetit1, Yvette Conley2, Nancy L McCain1.   

Abstract

Personalized medicine applies knowledge about the patient's individual characteristics in relation to health and intervention outcomes, including treatment response and adverse side-effects, to develop a tailored treatment plan. For women with breast cancer, personalized medicine has substantially improved the rate of survival, however, a high proportion of these women report multiple, co-occurring psychoneurological symptoms over the treatment trajectory that adversely affect their quality of life. In a subset of these women, co-occurring symptoms referred to as symptoms clusters, can persist long after treatment has ended. Over the past decade, research from the field of nursing and other health sciences has specifically examined the potential underlying mechanisms of the psychoneurological symptom cluster in women with breast cancer. Recent findings suggest that epigenetic and genomic factors contribute to inter-individual variability in the experience of psychoneurological symptoms during and after breast cancer treatment. While nursing research has been underrepresented in the field of personalized medicine, these studies represent a shared goal; that is, to improve patient outcomes by considering the individual's risk of short- and long-term adverse symptoms. The aim of this paper is to introduce a conceptual model of the individual variations that influence psychoneurological symptoms in women with breast cancer, including perceived stress, hypothalamic-pituitary adrenocortical axis dysfunction, inflammation, as well as epigenetic and genomic factors. The proposed concepts will help bring nursing research and personalized medicine together, in hopes that this hitherto neglected and understudied area of biomedical research convergence may ultimately lead to the development of more targeted clinical nursing strategies in breast cancer patients with psychoneurological symptoms.

Entities:  

Keywords:  Breast cancer; epigenetics; genetics; hypothalamic-pituitary-adrenal axis; personalized medicine; psychoneuroimmunology; psychoneurological symptoms; symptom clusters

Year:  2013        PMID: 24497894      PMCID: PMC3909649          DOI: 10.2174/18756921113119990004

Source DB:  PubMed          Journal:  Curr Pharmacogenomics Person Med        ISSN: 1875-6913


  67 in total

1.  Gene expression signature in peripheral blood cells from medical students exposed to chronic psychological stress.

Authors:  Tomoko Kawai; Kyoko Morita; Kiyoshi Masuda; Kensei Nishida; Michiyo Shikishima; Masayuki Ohta; Toshiro Saito; Kazuhito Rokutan
Journal:  Biol Psychol       Date:  2007-07-31       Impact factor: 3.251

2.  Implementing a comprehensive approach to the study of health dynamics using the psychoneuroimmunology paradigm.

Authors:  Nancy L McCain; Dorothy Patricia Gray; Jeanne M Walter; JoLynne Robins
Journal:  ANS Adv Nurs Sci       Date:  2005 Oct-Dec       Impact factor: 1.824

Review 3.  Biological basis of the behavior of sick animals.

Authors:  B L Hart
Journal:  Neurosci Biobehav Rev       Date:  1988       Impact factor: 8.989

4.  Altered cortisol response to psychologic stress in breast cancer survivors with persistent fatigue.

Authors:  Julienne E Bower; Patricia A Ganz; Najib Aziz
Journal:  Psychosom Med       Date:  2005 Mar-Apr       Impact factor: 4.312

5.  The canonical NF-κB pathway differentially protects normal and human tumor cells from ROS-induced DNA damage.

Authors:  Alexandros Sfikas; Christina Batsi; Evangelia Tselikou; George Vartholomatos; Nikolaos Monokrousos; Periklis Pappas; Savvas Christoforidis; Theodoros Tzavaras; Panagiotis Kanavaros; Vassilis G Gorgoulis; Kenneth B Marcu; Evangelos Kolettas
Journal:  Cell Signal       Date:  2012-06-29       Impact factor: 4.315

6.  Interaction of childhood maltreatment with the corticotropin-releasing hormone receptor gene: effects on hypothalamic-pituitary-adrenal axis reactivity.

Authors:  Audrey R Tyrka; Lawrence H Price; Joel Gelernter; Caroline Schepker; George M Anderson; Linda L Carpenter
Journal:  Biol Psychiatry       Date:  2009-07-12       Impact factor: 13.382

7.  'Chemobrain' in breast carcinoma?: a prologue.

Authors:  Jeffrey S Wefel; Renato Lenzi; Richard Theriault; Aman U Buzdar; Scott Cruickshank; Christina A Meyers
Journal:  Cancer       Date:  2004-08-01       Impact factor: 6.860

8.  Predictors of the intensity of symptoms in a cluster in patients with breast cancer.

Authors:  Hee-Ju Kim; Andrea M Barsevick; Lorraine Tulman
Journal:  J Nurs Scholarsh       Date:  2009       Impact factor: 3.176

Review 9.  The molecular mechanisms underlying the regulation of the biological activity of corticotropin-releasing hormone receptors: implications for physiology and pathophysiology.

Authors:  Edward W Hillhouse; Dimitris K Grammatopoulos
Journal:  Endocr Rev       Date:  2006-02-16       Impact factor: 19.871

10.  miR-18a impairs DNA damage response through downregulation of ataxia telangiectasia mutated (ATM) kinase.

Authors:  Libing Song; Chuyong Lin; Zhiqiang Wu; Hui Gong; Yong Zeng; Jueheng Wu; Mengfeng Li; Jun Li
Journal:  PLoS One       Date:  2011-09-27       Impact factor: 3.240

View more
  11 in total

1.  Metastatic breast cancer patients' expectations and priorities for symptom improvement.

Authors:  Danielle B Tometich; Catherine E Mosher; Adam T Hirsh; Kevin L Rand; Shelley A Johns; Marianne S Matthias; Samantha D Outcalt; Bryan P Schneider; Lida Mina; Anna Maria V Storniolo; Erin V Newton; Kathy D Miller
Journal:  Support Care Cancer       Date:  2018-05-07       Impact factor: 3.603

Review 2.  Symptom Cluster Research With Biomarkers and Genetics Using Latent Class Analysis.

Authors:  Samantha Conley
Journal:  West J Nurs Res       Date:  2016-12-05       Impact factor: 1.967

3.  Pilot Study of Metabolomics and Psychoneurological Symptoms in Women With Early Stage Breast Cancer.

Authors:  Debra E Lyon; Angela Starkweather; Yingwei Yao; Timothy Garrett; Debra Lynch Kelly; Victoria Menzies; Paweł Dereziński; Susmita Datta; Sreelakshmy Kumar; Colleen Jackson-Cook
Journal:  Biol Res Nurs       Date:  2017-12-19       Impact factor: 2.522

4.  Differences in symptom clusters before and twelve months after breast cancer surgery.

Authors:  Melissa Mazor; Janine K Cataldo; Kathryn Lee; Anand Dhruva; Bruce Cooper; Steven M Paul; Kimberly Topp; Betty J Smoot; Laura B Dunn; Jon D Levine; Yvette P Conley; Christine Miaskowski
Journal:  Eur J Oncol Nurs       Date:  2017-12-19       Impact factor: 2.398

5.  Systematic review of genetic polymorphisms associated with psychoneurological symptoms in breast cancer survivors.

Authors:  Gee Su Yang; Sreelakshmy Kumar; Susan G Dorsey; Angela R Starkweather; Debra Lynch Kelly; Debra E Lyon
Journal:  Support Care Cancer       Date:  2018-10-20       Impact factor: 3.603

6.  Pretreatment Psychoneurological Symptoms and Their Association With Longitudinal Cognitive Function and Quality of Life in Older Breast Cancer Survivors.

Authors:  Danielle B Tometich; Brent J Small; Judith E Carroll; Wanting Zhai; George Luta; Xingtao Zhou; Lindsay C Kobayashi; Tim Ahles; Andrew J Saykin; Jonathan D Clapp; Heather S L Jim; Paul B Jacobsen; Arti Hurria; Deena Graham; Brenna C McDonald; Neelima Denduluri; Martine Extermann; Claudine Isaacs; Asma Dilawari; James Root; Christine Rini; Jeanne S Mandelblatt
Journal:  J Pain Symptom Manage       Date:  2018-11-23       Impact factor: 3.612

7.  Systematic Review of the Kynurenine Pathway and Psychoneurological Symptoms Among Adult Cancer Survivors.

Authors:  Hongjin Li; Tingting Liu; Lacey W Heinsberg; Mark B Lockwood; Derek A Wainwright; Min Kyeong Jang; Ardith Z Doorenbos
Journal:  Biol Res Nurs       Date:  2020-06-30       Impact factor: 2.522

Review 8.  Inflammatory Markers, Metabolic Profile, and Psychoneurological Symptoms in Women with Breast Cancer: A Literature Review.

Authors:  Ahmad M Al-Bashaireh; Omar Khraisat; Eman K Alnazly; Mohannad Aldiqs
Journal:  Cureus       Date:  2021-11-28

Review 9.  Neurocognitive Impairment After Hematopoietic Stem Cell Transplant for Hematologic Malignancies: Phenotype and Mechanisms.

Authors:  Rebecca A Harrison; Noha Sharafeldin; Jennie L Rexer; Brennan Streck; Melissa Petersen; Ashley M Henneghan; Shelli R Kesler
Journal:  Oncologist       Date:  2021-07-12

10.  Cognitive dysfunction prevalence and associated factors in older breast cancer survivors.

Authors:  Adele Crouch; Victoria L Champion; Frederick W Unverzagt; Susan J Pressler; Lesa Huber; Lyndsi R Moser; David Cella; Diane Von Ah
Journal:  J Geriatr Oncol       Date:  2021-07-08       Impact factor: 3.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.